Redsenol-1 Plus Added to National Cancer Institute's Drug Dictionary
25 Feb 2025 | 0 Comments
Redsenol, an innovative leader in ginseng and ginsenoside research and application, is excited to announce that its natural health product, Redsenol-1 Plus, has been officially included in the National Cancer Institute's (NCI) Drug Dictionary. This milestone underscores Redsenol's dedication to advancing cancer research and the significant potential of Redsenol-1 Plus in cancer research and treatment.The NCI Drug Dictionary serves as a comprehensive resource for technical definitions and synonyms of drugs and agents used to treat patients with cancer or conditions related to cancer. Redsenol-1 Plus is now defined within this authoritative database as: “an oral and herbal supplement containing sixteen ginsenosides derived from ginseng and including the ginsenoside monomers Rg3(R, S), Rh1(S, R), Rh2(R, S), Rk1, Rk3, Rg5, Rh3, Rh4, Rk2, aPPD(S, R) and aPPT(S, R)....”This definition highlights the unique advantage of Redsenol-1 Plus: its rich profile of rare ginsenosides. Unlike most ginseng extracts that primarily feature the large, poorly absorbed prototype ginsenosides such as Rg1, Rb1, and Rc, Redsenol-1 Plus contains sixteen highly bioactive and absorbable rare ginsenosides at a concentration of 20%, significantly surpassing counterpart products that typically contain only 4% total ginsenosides.Redsenol's proprietary technologies, encompassing extraction, processing, transformation, and formulation of rare ginsenosides, enable large-scale production of these valuable compounds. This technological edge establishes Redsenol as a global leader in ginsenoside innovation, setting it apart in the market.The inclusion of Redsenol-1 Plus in the NCI Drug Dictionary also coincides with the company's ongoing clinical trial focused on cancer-related fatigue. Clinical trials involving cancer patients are inherently rigorous and challenging, but Redsenol's initiative reflects its dedication to advancing cancer research. The success of this trial could position Redsenol-1 Plus as a groundbreaking solution for cancer-related fatigue. Redsenol continues to be at the forefront of ginseng and ginsenoside research and application, driven by its mission to unlock the full potential of these natural compounds for the benefit of patients worldwide.
Related Product
Redsenol-1 Plus Noble Ginsenoside Capsules Contain 16 Rare Ginsenosides- 3 Boxes x 90 Capsules
Use code RED123 to save 10% on 5 or more items (based on the standard price of C$419). ..
CAD $409.00 CAD $419.00
Redsenol Buddle-REDSENOL-1Plus (3 Boxes) & REDSENOL DAG (2 Bottles) Rare Ginsenosides- Multicomponent Highly Bioactive Rare Ginsenosides
Multifactorial Actions of Sixteen Rare Ginsenosides to Exert Synergistic Benefits ..
CAD $820.00 CAD $838.00
Redsenol DAG Sublingual Pills- Highly Active Rare Ginsenosides:Rk2 Rh3 aPPD Rg5, aPPD, aPPT- 2 Boxes x 480 Pills
Use code RED123 to save 10% on 5 or more items (based on the standard price of C$419). ..
CAD $409.00 CAD $419.00
Each month, we will pick 2 of the best photo/video posts and offer a
C$20 Walmart eGift Card or a C$30 Redsenol Coupon Code
for the next order purchase to the lucky winners.